PLS results
| Exogenous constructs | Endogenous constructs | |||||
|---|---|---|---|---|---|---|
| FDA | RDA | DV | ||||
| (β) | t-value | (β) | t-value | (β) | t-value | |
| H1: EO | 0.284* | 2.249 | ||||
| H2: EO | 0.087 | 0.685 | ||||
| H3: FDA | 0.321** | 2.757 | ||||
| H4: FDA | 0.129 | 1.167 | ||||
| H5: RDA | 0.384** | 3.474 | ||||
| Control variables | ||||||
| Marketing communication capability | 0.037 | 0.178 | ||||
| Brand fit | 0.149 | 1.381 | ||||
| Component importance | −0.054 | 0.387 | ||||
| Industry | −0.010 | 0.087 | ||||
| Company size | −0.121 | 1.205 | ||||
| Relationship tenure | −0.150 | 1.155 | ||||
| Manager tenure with the company | −0.042 | 0.279 | ||||
| R2 (%) | 8.1% | 13.3% | 34.4% | |||
| R2 (control only model) (%) | 0.7% | 16.4% | ||||
| Exogenous constructs | Endogenous constructs | |||||
|---|---|---|---|---|---|---|
| RDA | DV | |||||
| t-value | (β) | (β) | ||||
| 0.284 | 2.249 | |||||
| 0.087 | 0.685 | |||||
| 0.321 | 2.757 | |||||
| 0.129 | 1.167 | |||||
| 0.384 | 3.474 | |||||
| 0.037 | 0.178 | |||||
| 0.149 | 1.381 | |||||
| −0.054 | 0.387 | |||||
| −0.010 | 0.087 | |||||
| −0.121 | 1.205 | |||||
| −0.150 | 1.155 | |||||
| −0.042 | 0.279 | |||||
| 8.1% | 13.3% | 34.4% | ||||
| 0.7% | 16.4% | |||||
Notes:
n = 77; *p < 0.05 (two-tailed); **p < 0.01 (two-tailed)
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.